myozyme® (alglucosidase alfa) 50mg powder for solution for infusion
sanofi-aventis singapore pte. ltd. - alglucosidase alfa - injection, powder, lyophilized, for solution - 52.5 mg - alglucosidase alfa 50 mg/vial
myozyme
sanofi israel ltd - alglucosidase alfa - powder for concentrate for infusion - alglucosidase alfa 50 mg/vial - alglucosidase alfa - alglucosidase alfa - myozyme is indicated for long-term enzyme replacement therapy (ert) in patients with a confirmed diagnosis of pompe disease (acid alpha-glucosidase deficiency). the benefits of myozyme in patients with late-onset pompe disease have not been established.
myozyme
sanofi b.v. - alglucosidase alfa - glycogen storage disease type ii - other alimentary tract and metabolism products, - myozyme is indicated for long-term enzyme-replacement therapy (ert) in patients with a confirmed diagnosis of pompe disease (acid-α-glucosidase deficiency).in patients with late-onset pompe disease the evidence of efficacy is limited.
myozyme powder for solution
sanofi genzyme, a division of sanofi-aventis canada inc - alglucosidase alfa - powder for solution - 50mg - alglucosidase alfa 50mg - enzymes
myozyme 50mg powder for concentrate for solution for infusion vials
genzyme therapeutics ltd - alglucosidase alfa - powder for solution for infusion - 50mg
alglucosidase alfa 800mg/500ml infusion bags
special order - alglucosidase alfa - infusion - 1.6mg/1ml
alglucosidase alfa 950mg/500ml infusion bags
special order - alglucosidase alfa - infusion - 1.9mg/1ml
alglucosidase alfa 1g/500ml infusion bags
special order - alglucosidase alfa - infusion - 2mg/1ml
alglucosidase alfa 1.1g/500ml infusion bags
special order - alglucosidase alfa - infusion - 2.2mg/1ml
alglucosidase alfa 1.15g/500ml infusion bags
special order - alglucosidase alfa - infusion - 2.3mg/1ml